2.74
price up icon0.74%   0.02
pre-market  Vorhandelsmarkt:  2.74  
loading
Schlusskurs vom Vortag:
$2.72
Offen:
$2.71
24-Stunden-Volumen:
159.08K
Relative Volume:
1.94
Marktkapitalisierung:
$865.37M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-11.46M
KGV:
-0.1957
EPS:
-14
Netto-Cashflow:
$-24.56M
1W Leistung:
+16.10%
1M Leistung:
+74.52%
6M Leistung:
-62.21%
1J Leistung:
-84.43%
1-Tages-Spanne:
Value
$2.5262
$2.83
1-Wochen-Bereich:
Value
$2.1705
$2.83
52-Wochen-Spanne:
Value
$1.20
$19.95

Evaxion A S Adr Stock (EVAX) Company Profile

Name
Firmenname
Evaxion A S Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
46
Name
Twitter
Name
Nächster Verdiensttermin
2024-10-31
Name
Neueste SEC-Einreichungen
Name
EVAX's Discussions on Twitter

Vergleichen Sie EVAX mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
EVAX
Evaxion A S Adr
2.74 14.91M 0 -11.46M -24.56M -14.00
Biotechnology icon
ONC
Beone Medicines Ltd Adr
251.72 25.78B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
446.48 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.3401 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.81 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
487.86 65.13B 14.09B 4.50B 2.96B 39.28

Evaxion A S Adr Stock (EVAX) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2024-04-02 Hochstufung Ladenburg Thalmann Neutral → Buy
2024-02-12 Eingeleitet H.C. Wainwright Buy

Evaxion A S Adr Aktie (EVAX) Neueste Nachrichten

pulisher
May 31, 2025

Evaxion Biotech’s Earnings Call Highlights Progress and Challenges - MSN

May 31, 2025
pulisher
May 27, 2025

Evaxion Biotech Reports Q1 2025 Progress and Financials - TipRanks

May 27, 2025
pulisher
May 27, 2025

European ADRs Rise On S&P Europe Select Index - Finimize

May 27, 2025
pulisher
May 23, 2025

Evaxion to announce business update and first quarter 2025 financial results on May 27, 2025 - GlobeNewswire Inc.

May 23, 2025
pulisher
May 15, 2025

European Equities See Growth In US Trade - Finimize

May 15, 2025
pulisher
Apr 28, 2025

80% of the EVX-01 vaccine targets trigger a tumor-reactive immune response - GlobeNewswire Inc.

Apr 28, 2025
pulisher
Apr 28, 2025

Evaxion’s EVX-01 vaccine shows promising immune response in trial - Investing.com

Apr 28, 2025
pulisher
Apr 24, 2025

European Equities Traded in the US as American Depositary Receipts Sharply Higher in Wednesday Trading - MSN

Apr 24, 2025
pulisher
Apr 07, 2025

European Equities Traded in the US as American Depositary Receipts Drop in Monday Trading - TradingView

Apr 07, 2025
pulisher
Apr 04, 2025

European Stocks Slip In US Trading With Mixed Performances - Finimize

Apr 04, 2025
pulisher
Apr 02, 2025

Evaxion Biotech’s Optimistic Earnings Call Highlights - TipRanks

Apr 02, 2025
pulisher
Apr 02, 2025

Evaxion Biotech Reports 2024 Financial Results and Strategic Progress - TipRanks

Apr 02, 2025
pulisher
Apr 01, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Tuesday Trading - TradingView

Apr 01, 2025
pulisher
Apr 01, 2025

Earnings call transcript: Evaxion Biotech Q4 2024 sees improved financials - Investing.com

Apr 01, 2025
pulisher
Mar 26, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading - TradingView

Mar 26, 2025
pulisher
Mar 25, 2025

Evaxion Biotech stock plunges to 52-week low of $1.7 amid steep annual decline - Investing.com

Mar 25, 2025
pulisher
Mar 20, 2025

European Equities Traded in the US as American Depositary Receipts Trend Lower in Thursday Trading - TradingView

Mar 20, 2025
pulisher
Mar 13, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Thursday Trading - TradingView

Mar 13, 2025
pulisher
Mar 11, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading - TradingView

Mar 11, 2025
pulisher
Mar 10, 2025

European Equities Traded in the US as American Depositary Receipts Fall in Monday Trading - TradingView

Mar 10, 2025
pulisher
Mar 04, 2025

European Equities Traded in the US as ADRs Fall in Tuesday Trading - TradingView

Mar 04, 2025
pulisher
Mar 04, 2025

Evaxion Biotech stock hits 52-week low at $1.79 amid market challenges - Investing.com

Mar 04, 2025
pulisher
Feb 28, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading, Remain Flat for Week - TradingView

Feb 28, 2025
pulisher
Feb 26, 2025

EVAX: Extended Trial is Excellent News - Research Tree

Feb 26, 2025
pulisher
Feb 25, 2025

Evaxion Biotech A/SADR to Host Earnings Call - ACCESS Newswire

Feb 25, 2025
pulisher
Feb 25, 2025

Evaxion Biotech stock hits 52-week low at $2.22 amid sharp decline - Investing.com

Feb 25, 2025
pulisher
Feb 24, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading - TradingView

Feb 24, 2025
pulisher
Feb 18, 2025

Evaxion Biotech A/S ADR (EVAX) Receives Upgrades Amid Sharp Decline – Is It Time for Investors to Reevaluate? - HPBL

Feb 18, 2025
pulisher
Feb 16, 2025

Evaxion Biotech (EVAX) Stock Analysis: Price Decline, Analyst Ratings and Financial Ratios – market - HPBL

Feb 16, 2025
pulisher
Feb 14, 2025

Evaxion secures Nasdaq listing with equity boost - Investing.com

Feb 14, 2025
pulisher
Feb 12, 2025

European Equities Traded in the US as American Depositary Receipts Tread Water in Wednesday Trading - TradingView

Feb 12, 2025
pulisher
Feb 08, 2025

After A Decline Of -818.6% From The High, Can Evaxion Biotech A/S ADR (NASDAQ: EVAX) Recover Quickly? - Marketing Sentinel

Feb 08, 2025
pulisher
Feb 07, 2025

European Equities Traded in the US as American Depositary Receipts Lower in Friday Trading, End Week Up 3.2% - TradingView

Feb 07, 2025
pulisher
Feb 06, 2025

Top investors say Evaxion Biotech A/S ADR (EVAX) ticks everything they need - SETE News

Feb 06, 2025
pulisher
Feb 05, 2025

Evaxion Biotech A/S ADR [EVAX] Investment Guide: What You Need to Know - Knox Daily

Feb 05, 2025
pulisher
Feb 05, 2025

Now Is The Time To Build A Position In Evaxion Biotech A/S ADR (NASDAQ:EVAX) - Marketing Sentinel

Feb 05, 2025
pulisher
Feb 04, 2025

Evaxion Biotech A/S ADR (EVAX) Stock: A Year of Stock Market Ups and Downs - The InvestChronicle

Feb 04, 2025
pulisher
Feb 04, 2025

Palantir Technologies Surges 16.5% in Pre-Market Trading After Strong Q4 Earnings Report - HPBL

Feb 04, 2025
pulisher
Feb 04, 2025

European Equities Traded in the US as American Depositary Receipts Rise in Tuesday Trading - TradingView

Feb 04, 2025
pulisher
Feb 04, 2025

Spyre Therapeutics Inc (SYRE) stock analysis: A comprehensive overview - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Argo Blockchain Plc ADR (ARBK)’s stock price in review: A technical analysis - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Evaxion Biotech A/S ADR (EVAX)’s stock decline to 2.40 per share - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Daily Market Movement: Onconetix Inc (ONCO) Sees a 11.91 Increase, Closing at 0.61 - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

In the Green: Evaxion Biotech A/S ADR (EVAX) Closes at 2.40, Up/Down -2.24 from Previous Day - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Market Insights: Kairos Pharma Ltd (KAPA)’s Notable Gain of 6.29, Closing at 1.52 - The Dwinnex

Feb 04, 2025
pulisher
Feb 03, 2025

Palantir Technologies at a Crossroads: Sky-High Valuation or Looming Market Correction? - HPBL

Feb 03, 2025
pulisher
Feb 03, 2025

Hodges Capital Management Takes $16.5 Million Stake in Palantir Technologies (PLTR) – market - HPBL

Feb 03, 2025
pulisher
Feb 03, 2025

H.C. Wainwright maintains Evaxion stock Buy rating, $14 target - Investing.com

Feb 03, 2025
pulisher
Jan 31, 2025

Major Pharma Giant's VC Fund Doubles Down on Evaxion Biotech in $10.8M Strategic Round - StockTitan

Jan 31, 2025
pulisher
Jan 31, 2025

European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading - TradingView

Jan 31, 2025
pulisher
Jan 30, 2025

Evaxion Biotech stock hits 52-week low at $2.38 amid market challenges - Investing.com

Jan 30, 2025

Finanzdaten der Evaxion A S Adr-Aktie (EVAX)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$1.16
price up icon 0.87%
$31.13
price down icon 0.19%
$576.61
price down icon 1.37%
$303.77
price down icon 0.76%
$4.5807
price down icon 0.41%
$487.86
price down icon 0.60%
Kapitalisierung:     |  Volumen (24h):